Rege Nephro Co., Ltd. Successfully Completes Series B Funding to Accelerate Kidney ...
Rege Nephro Co., Ltd. raised 22.5 billion yen in Series B funding, totaling 44 billion yen. The funds will advance RN-014's Phase II trials for ADPKD and prepare for U.S. trials, plus support RN-032's preclinical trials for CKD.
© Copyright 2025. All Rights Reserved by MedPath